Devices

Architectural considerations for building traceable, evidence-ready device systems intended for regenerative delivery, including consumable authentication, telemetry, and audit paths.

A methodology summary for evaluating delivery systems across relevant preclinical models, including endpoints, controls, and reporting standards.

System and methods for authenticating single-use consumables in a connected regenerative delivery platform, including cryptographic pairing and use-count enforcement.

Regulatory-classification considerations for connected regenerative medical device platforms, mapping features to expected review pathways.